Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 791 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification from Shalby Limited about the schedule of an earnings conference call to discuss Q4 FY 2025 earnings. It includes details such as date, time, participants, and dial-in numbers for the call. The document does not contain actual financial results or detailed financial statements but is an announcement of the upcoming earnings call event. According to the classification rules, such a document is best classified as a Call Transcript (CT) category, as it relates to the earnings conference call. However, since this document is only the schedule/announcement of the call and not the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the call schedule, not the transcript or the earnings release itself. The document length is short (2830 characters), and it is an announcement rather than the report or transcript itself. Therefore, the best fit is Regulatory Filings (RNS).
2025-05-24 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-20 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a formal notice from Shalby Limited to stock exchanges about an upcoming Board Meeting scheduled for May 29, 2025. The purpose of the meeting is to consider and approve the audited financial results for the quarter and year ended March 31, 2025, and to recommend a dividend for the financial year 2024-25. The document also mentions the closure of the trading window for insiders. The document does not contain the financial results themselves but is an announcement of the meeting where these results will be approved and dividend recommended. The document length is short (1907 characters) and it serves as an intimation or notice rather than the actual financial report or dividend declaration. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notice to exchanges rather than a full financial report or dividend notice.
2025-05-20 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialized/rematerialized securities details furnished to stock exchanges. The document is short (3140 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance certificates and miscellaneous filings that do not fit other categories.
2025-04-07 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the year ended March 31, 2025. It confirms that none of the promoters or promoter group have made any encumbrance, pledge, or transfer of equity shares and that shares are free from encumbrance as of the fiscal year-end. This is a regulatory disclosure related to shareholding and encumbrance status, not a full report or financial statement. The document is short (1266 characters) and is a formal notification to stock exchanges. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes or confirmations in significant share ownership or encumbrance status under SEBI regulations.
2025-04-04 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.